New hope for ovarian cancer patients! In this in-depth interview, leading gynecologic oncologist Dr. Alexander Olawaiye discusses the devastating "silent killer" — ovarian cancer — and the recent FDA approval of Lifyorli (relacorilant), a groundbreaking new drug for platinum-resistant cases. In this #DoctorPodcasts episode # 154, Dr. Olawaiye, a key investigator in the pivotal ROSella Phase 3 trial, explains the biology of the disease, why early detection is so difficult, standard treatments, and how Lifurley + nab-paclitaxel significantly improves progression-free and overall survival. Key Topics Covered: Why ovarian cancer is often diagnosed late (Stage 3–4)Symptoms, diagnosis challenges, and current limitations in screening.Platinum-resistant ovarian cancer explained.How Lifyorli works (cortisol receptor mechanism).ROSella trial results: survival benefits and safety profile.Future of antibody-drug conjugates and AI in gynecologic oncology.Importance of clinical trial participation.Watch this DoctorPodcasts Episode 154 with host, Dr. Robert Cykiert.Guest:Dr. Alexander Olawaiye, MDProfessor of Gynecologic Oncology, University of Pittsburgh / Magee-Women’s HospitalKey Investigator, ROSella Trial Timestamps:0:00 Intro & Welcome2:14 What is ovarian cancer? Why the "silent killer"?3:56 Symptoms and late-stage diagnosis6:16 How ovarian cancer is diagnosed (CA-125, imaging, etc.)8:04 Why current screening (CA-125, ultrasound, MRI) doesn't work13:28 Prognosis and platinum-based chemotherapy15:29 Platinum-resistant ovarian cancer explained18:35 Lifurley (relacorilant) + nab-paclitaxel: New FDA-approved treatment21:04 Mechanism of action and how it overcomes resistance23:55 ROSella Phase 3 Trial results – survival data30:52 Side effects and tolerability32:33 Future developments (antibody-drug conjugates, more trials)37:09 Importance of research & clinical trials41:45 Final thoughts and hope for patientsIf you or a loved one has been affected by ovarian cancer, this episode offers critical, up-to-date information from a top expert. Subscribe for more physician-led discussions on breakthrough treatments, cancer care, and women's health. Like, comment, and share to help others find this information! #OvarianCancer #Lifurley #CancerTreatment #ROSellaTrial #GynecologicOncology #WomensHealth #NewCancerDrug #PlatinumResistant #HarvardTrained #ClinicalTrials

Is your grocery list silently destroying your brain? 🧠 A groundbreaking new Harvard T.H. Chan School of Public Health study published in the American Journal of Public Health reveals that eating ultra-processed foods (UPFs) like packaged snacks, sodas, and deli meats can skyrocket your risk of developing dementia by a staggering 58%! 🚨 In this episode, nutrition expert Dr. Cindy Leung exposes the corporate greed, aggressive marketing tactics, and addictive formulations that mirror the dark history of Big Tobacco. As the U.S. government rolls out sweeping updates under the "Make America Healthy Again" guidelines to target food dyes, toxic additives, and ultra-processed ingredients, we dive deep into the biological mechanics—from gut microbiome inflammation to severe glucose spikes—that are driving this national health emergency. If you are ready to uncover the truth about what is really on your plate and take control of your long-term cognitive health, hit that SUBSCRIBE button, smash the LIKE button, and drop a comment below sharing the one food you are throwing out today! 👇00:00 - Big Tobacco Tactics & The Addictive Food Loop Addictive ultra-processed foods, hyper-palatable junk food, food company marketing strategies, tobacco industry food secrets.01:15 - Introducing Dr. Cindy Leang & The Harvard Study Harvard nutrition expert, American Journal of Public Health study, Harvard T.H. Chan epidemiology, diet and cognitive decline.03:26 - The Persistence of Food Insecurity & The Economy Food bank trends, SNAP food assistance, poverty and poor diet, living wage and grocery budgets.07:20 - Defining NOVA Classification 1 vs. NOVA 4NOVA food processing categories, minimally processed foods examples, factory-made foods vs. kitchen cooking.09:08 - The Biology of Junk Food Addiction & Cravings Dopamine release from sugar, food addiction criteria, plastic packaged shelf-stable snacks.12:23 - The Big Numbers: 58% Higher Dementia Risk Mild cognitive impairment statistics, 58 percent higher dementia risk, Health and Retirement Study Michigan, whole foods risk reduction.15:52 - Biological Mechanisms: Gut Microbiome & Glucose Spikes Insulin resistance brain damage, gut-brain axis inflammation, high blood sugar blood vessels, type 2 diabetes dementia risk.20:23 - Corporate Profit Margins & Serving Size Tricks CPG industry profits, child targeted food marketing, misleading nutrition labels, corporate food greed.22:35 - The Stress Matrix: Why Low-Income Families Rely on UPFs Food deserts San Francisco, mental health and food insecurity, budget-friendly cheap cereal, shelf-stable frozen dinner choices.26:22 - Government Policy: Banning Food Ads & Closing Loopholes Make America Healthy Again nutrition, Robert F. Kennedy Jr HHS, GRAS loophole FDA regulations, taxing sugary beverages, banning food TV ads.31:37 - The Impact of GLP-1 Drugs (Ozempic/Wegovy) on Food SalesGLP-1 weight loss drug impact, Ozempic changing food industry, suppressing junk food cravings.32:56 - Final Takeaway: Systemic Overhaul, Not Personal Failure Overhauling the food system, consumer advocacy nutrition policy, real food nutrition reform.#UltraProcessedFoods #DementiaRisk #HarvardStudy #MAHA #GutBrainAxis #BrainHealth

EPISODE 152:Did you know millions suffer from complicated UTIs (Urinary Tract Infections) yearly, and 13,000 die from them in the US alone due to infection spread to kidneys and blood? Discover how a groundbreaking new FDA-approved antibiotic, ZAYNICH, is changing the game against drug-resistant superbugs. In Episode 152 of #DoctorPodcasts, host Dr. Robert Cykiert sits down with Dennis Deruelle, M.D., Chief Medical Officer for Wockhardt USA @WockhardtLtd pharmaceutical company. They break down the critical differences between simple bladder infections and complicated UTIs like pyelonephritis (kidney infections) which can lead to #sepsis and death. Dr. Deruelle discusses how bacteria mutate to outsmart current drugs using biofilms, plasmids and efflux pumps, creating dangerous multi-drug resistant superbugs. It's evolution and survival of the fittest in real-time in the bacteria world. Learn about "ZAYNICH" a newly FDA-approved intravenous antibiotic engineered specifically to target certain complex bacterial mutated strains and save lives. If you find this medical breakthrough informative, please LIKE, COMMENT, and SUBSCRIBE to help us bring you more expert insights!

0:00 - Introduction to Episode 152 & Dr. Dennis Deruelle

2:02 - What is a UTI & Who is Most At Risk?

4:15 - Typical Symptoms of a Bladder Infection

4:56 - Complicated vs. Uncomplicated UTIs: The New Guidelines

6:49 - Risk Factors for Severe & Catheter-Associated UTIs 8:22 - Why Oral Antibiotics Fail in Complex Infections

11:15 - Pyelonephritis: How Bacteria Reach the Kidneys

12:35 - Systemic Symptoms & Mental Status Changes in the Elderly

14:35 - Shocking UTI Statistics: Hospitalizations & Mortality 16:10 - The Biofilm Secret Weapon: How Superbugs Protect Themselves

17:15 - Evolution in Real-Time: How Bacteria Become Drug-Resistant

22:31 - ZAYNICH: The New FDA-Approved Breakthrough Antibiotic

24:00 - Phase 3 Clinical Trial Data & Efficacy Results

27:25 - The Rise of MBL Mutations in the United States

29:19 - Which Drug-Resistant Superbugs Does ZAYNICH Target?

31:36 - How Plasmids Spread Drug Resistance Across the Body 32:25 - Safety, Side Effects, & Clinical Success Rates

34:30 - Future Clinical Trials & Compassionate Use Cases 37:32 - Outro & Final Expert Thoughts

#UTI

#AntibioticResistance

#MedicalNews

#Superbugs

#Urology

#Wockhardt

#FDAApproved

#HealthBreakthrough

#Pyelonephritis